Microenvironment and Immunology
Snail1-Expressing Fibroblasts in the Tumor
Microenvironment Display Mechanical Properties
That Support Metastasis
Jelena Stanisavljevic
1
, Jordina Loubat-Casanovas
1
, Mercedes Herrera
2
, Tom as Luque
3,4
,
Ra ul Pe ~ na
1
, Ana Lluch
5,6
, Joan Albanell
7,8,9
,F elix Bonilla
2
, Ana Rovira
7,8
, Cristina Pe ~ na
2
,
Daniel Navajas
3,4,12
, Federico Rojo
7,10,11
, Antonio García de Herreros
1,9
, and Josep Baulida
1
Abstract
Crosstalk between tumor and stromal cells in the tumor micro-
environment alter its properties in ways that facilitate the invasive
behavior of tumor cells. Here, we demonstrate that cancer-asso-
ciated fibroblasts (CAF) increase the stiffness of the extracellular
matrix (ECM) and promote anisotropic fiber orientation, two
mechanical signals generated through a Snail1/RhoA/aSMA–
dependent mechanism that sustains oriented tumor cell migra-
tion and invasiveness. Snail1-depleted CAF failed to acquire
myofibroblastic traits in response to TGFb, including RhoA acti-
vation, aSMA-positive stress fibers, increased fibronectin fibrillo-
genesis, and production of a stiff ECM with oriented fibers. Snail1
expression in human tumor–derived CAF was associated with an
ability to organize the ECM. In coculture, a relatively smaller
number of Snail1-expressing CAF were capable of imposing an
anisotropic ECM architecture, compared with nonactivated fibro-
blasts. Pathologically, human breast cancers with Snail1
þ
CAF
tended to exhibit desmoplastic areas with anisotropic fibers,
lymph node involvement, and poorer outcomes. Snail1 involve-
ment in driving an ordered ECM was further confirmed in wound-
healing experiments in mice, with Snail1 depletion preventing the
anisotropic organization of granulation tissue and delaying
wound healing. Overall, our results showed that inhibiting Snail1
function in CAF could prevent tumor-driven ECM reorganization
and cancer invasion. Cancer Res; 75(2); 284–95. Ó2014 AACR.
Introduction
Myofibroblasts are activated fibroblasts that remodel connec-
tive tissues in processes, such as development and wound healing
(1, 2). They typically contain contractile aSMA (smooth muscle
alpha actin)-positive stress fibers linked to and required for the
formation of supermature integrin focal contacts, named fibro-
nexus. Fibronexus transmits intracellular tensional forces to extra-
cellular fibronectin molecules, allowing their assemblage into
fibers (3). Extracellular fibronectin fibers facilitate and guide the
polymerization of other molecules, such as thrombospondin-1,
perostin, tenascin C (4), fibrillin, and collagen (5), into the
extracellular matrix (ECM).
aSMA-positive stress fibers also connect intercellular cadherin
junctions that permit them to withstand mechanical stress
between neighbor cells; indeed, adherens junctions of cultured
myofibroblasts are significantly larger than those of aSMA-neg-
ative fibroblasts (6). The ECM architecture of connective tissues
and the myofibroblast phenotype, including nuclei (7) and cell
shapes (3), ultimately depend on an intraextracellular tensional
dialog mediated by these specialized cell–substrate and cell–cell
structures.
Cancer-associated fibroblasts (CAF) are a heterogeneous
population of activated fibroblasts whose activity in the stroma
associates with tumor progression and malignancy. CAFs pro-
duce paracrine growth factors, proteolytic enzymes, and ECM
components, and contribute to generate a desmoplastic
response (fibrillar network deposition) around cancer cells
(8) similar to that at the granulation tissue of wounds. Thus,
CAF activity perturbs not only the biochemical but also the
biomechanical homeostasis of the tumor microenvironment;
these perturbances are sensed by tumor cells and ultimately
affect their behavior (9). In breast cancer, mechanical proper-
ties of the stroma, such as stiffness (10) and fiber alignment
(11), force progression of the disease. In fact, the presence of
dense and aligned collagen fibers around human breast carci-
nomas is a prognostic signature for poor survival (12, 13). CAFs
are permanently activated by a TGFb autocrine loop (14), and
1
Programa de Recerca en C ancer, Institut Hospital del Mar d'Investiga-
cions M ediques, Barcelona, Spain.
2
Department of Medical Oncology,
Puerta de Hierro Majadahonda University Hospital, Majadahonda,
Madrid, Spain.
3
Unitat de Biofísica i Bioenginyeria, Universitat de
Barcelona, Barcelona, Spain.
4
Institute for Bioengineering of Catalo-
nia, Barcelona, Spain.
5
Department of Oncology and Hematology,
Hospital Clínico Universitario, Valencia, Spain.
6
Department of Medi-
cine, Valencia Central University, Valencia, Spain.
7
Molecular Thera-
peutics and Biomarkers in Cancer Laboratory, Institut Hospital del Mar
d'Investigacions M ediques, Hospital del Mar, Barcelona, Spain.
8
Med-
ical Oncology Department, Hospital del Mar, Barcelona, Spain.
9
Depar-
tament de Ci encies Experimentals i de la Salut, Universitat Pompeu
Fabra, Barcelona, Spain.
10
Department of Pathology, IIS-Fundaci on
Jim enez Díaz, Madrid, Spain.
11
Department of Pathology, Hospital del
Mar, Barcelona, Spain.
12
Ciber Enfermedades Respiratorias (CIBERES),
07110-Bunyola, Spain.
Note: Supplementary data for this article are available at Cancer Research
Online (http://cancerres.aacrjournals.org/).
Corresponding Author: Josep Baulida, IMIM, C/Dr. Aiguader, 88, 08003, Bar-
celona, Spain. Phone: 34-3-316-0436; Fax: 34-3-316-0410. E-mail:
jbaulida@imim.es
doi: 10.1158/0008-5472.CAN-14-1903
Ó2014 American Association for Cancer Research.
Cancer
Research
Cancer Res; 75(2) January 15, 2015 284
on April 13, 2017. © 2015 American Association for Cancer Research. cancerres.aacrjournals.org Downloaded from
Published OnlineFirst December 8, 2014; DOI: 10.1158/0008-5472.CAN-14-1903